PharmAthene Reports First Quarter 2016 Financial and Operational Results
ANNAPOLIS, Md., May 9, 2016 - PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today...
Biodefense
ANNAPOLIS, Md., May 9, 2016 - PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today...